Gas Chromatographic Determination of Hexamethylene Bisacetamide in Plasma and Urine

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Analytical Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/00032718508069099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of differentiation in mouse neuroblastoma cells by hexamethylene bisacetamide.

  1977cited by this paper
• Clinical chemistry : theory and practice

  1969cited by this paper

• Approaches to optimal dosing of hexamethylene bisacetamide

  2004cites this paper
• Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions

  2004cites this paper
• Hexamethylene bisacetamide as a chemopreventive agent in hamster cheek pouch tumorigenesis.

  1996cites this paper
• Simultaneous measurement of the cell-differentiating agent hexamethylene bisacetamide and its metabolites by gas chromatography.

  1994cites this paper
• Metabolism of hexamethylene bisacetamide and its metabolites in leukemic cells.

  1988cites this paper
• Determination of hexamethylene bisacetamide by capillary gas chromatography.

  1987cites this paper
• Gas chromatographic analysis of metabolites of the cell differentiating agent hexamethylene bisacetamide.

  1987cites this paper
• Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.

  1987cites this paper